These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 29300420
1. Lower 25-Hydroxyvitamin D Is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis. Wang C, Zeng Z, Wang B, Guo S. J Nutr Health Aging; 2018; 22(1):38-43. PubMed ID: 29300420 [Abstract] [Full Text] [Related]
2. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Runia TF, Hop WC, de Rijke YB, Buljevac D, Hintzen RQ. Neurology; 2012 Jul 17; 79(3):261-6. PubMed ID: 22700811 [Abstract] [Full Text] [Related]
3. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis. Brola W, Sobolewski P, Szczuchniak W, Góral A, Fudala M, Przybylski W, Opara J. Eur J Clin Nutr; 2016 Sep 17; 70(9):995-9. PubMed ID: 27026420 [Abstract] [Full Text] [Related]
5. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R. Mult Scler; 2008 Nov 17; 14(9):1220-4. PubMed ID: 18653736 [Abstract] [Full Text] [Related]
6. Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients. Saltytė Benth J, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Holmøy T. Neuroepidemiology; 2012 Nov 17; 39(2):84-93. PubMed ID: 22814117 [Abstract] [Full Text] [Related]
8. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Simpson S, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I. Ann Neurol; 2010 Aug 17; 68(2):193-203. PubMed ID: 20695012 [Abstract] [Full Text] [Related]
10. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I. J Neurol Neurosurg Psychiatry; 2008 Feb 17; 79(2):152-7. PubMed ID: 17578859 [Abstract] [Full Text] [Related]
15. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b. Fitzgerald KC, Munger KL, Köchert K, Arnason BG, Comi G, Cook S, Goodin DS, Filippi M, Hartung HP, Jeffery DR, O'Connor P, Suarez G, Sandbrink R, Kappos L, Pohl C, Ascherio A. JAMA Neurol; 2015 Dec 17; 72(12):1458-65. PubMed ID: 26458124 [Abstract] [Full Text] [Related]
16. Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod. Ferre' L, Clarelli F, Sferruzza G, Rocca MA, Mascia E, Radaelli M, Sangalli F, Dalla Costa G, Moiola L, Aboulwafa M, Martinelli Boneschi F, Comi G, Filippi M, Martinelli V, Esposito F. Neurol Sci; 2018 Aug 17; 39(8):1467-1470. PubMed ID: 29756179 [Abstract] [Full Text] [Related]
17. Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. Smolders J, Menheere P, Thewissen M, Peelen E, Tervaert JW, Hupperts R, Damoiseaux J. J Steroid Biochem Mol Biol; 2010 Jul 17; 121(1-2):243-6. PubMed ID: 20211254 [Abstract] [Full Text] [Related]
18. Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis. Smolders J, Peelen E, Thewissen M, Menheere P, Damoiseaux J, Hupperts R. Mult Scler; 2014 Apr 17; 20(4):433-7. PubMed ID: 23959712 [Abstract] [Full Text] [Related]